Clinical Trials Update: May 18, 2004

Anemia Crohn's Disease Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)

(HealthDayNews) -- Here are the latest clinical trials, courtesy of CenterWatch:

Anemia

A research study of an investigational medication to see if it can increase red blood cell count and decrease the fatigue that may be caused by cancer-related anemia. Volunteers who have diagnosed with cancer, have recently completed chemotherapy or radiation therapy, and have been diagnosed with anemia may be eligible. Research site located in Staten Island, NY.

More information

Please see http://www.centerwatch.com/patient/studies/cat373.html.

-----

Crohn's Disease

A research study of an investigational medication to treat Crohn's disease. Volunteers at least 18 years old who have been diagnosed with Crohn's for at least six months and have not previously taken natalizumab may be eligible. Research sites located throughout the United States.

More information

Please see http://www.centerwatch.com/patient/studies/cat51.html.

-----

Attention Deficit/Hyperactivity Disorder (ADHD - Pediatric)

A research study to assess the effectiveness of an investigational medication to treat children and adolescents diagnosed with ADHD. Children and adolescents 6 - 17 who have been diagnosed with ADHD may be eligible. Research site located in Birmingham, Ala.

More information

Please see http://www.centerwatch.com/patient/studies/cat18.html.

-----

Copyright 2004 CenterWatch. All rights reserved.

Consumer News